StrongRoom AI (AI) — Funding, Investors & Signals 2026

StrongRoom AI

AI-driven controlled drugs management platform aimed at reducing adverse drug events.

Founded 2017

Australia 51 employees Non Equity Assistance Total: $20.00K AI, Computer Vision

StrongRoom AI is an AI-driven controlled drugs management platform with the ambitious goal of reducing adverse drug events. The platform addresses the pressing issue of adverse drug events, which inflicts a staggering annual cost of over $1 trillion on healthcare systems and contributes to 20% of all hospital admissions and readmissions globally. The company, founded in 2017 in Australia, combines two generations of software and machine learning to offer effective drug management solutions. By leveraging cutting-edge technology, StrongRoom AI aims to streamline and enhance administration outcomes for clinicians and care providers across pharmacy, aged care, and hospital facilities. The platform not only seeks to optimize the management of medications but also emphasizes the importance of data security. StrongRoom AI is committed to ensuring that patients receive the right medication at the right time, while safeguarding the integrity and privacy of their data. The company recently received a Non-Equity Assistance investment on 31 August 2023 from WorldUpstart, a testament to its potential and the confidence of investors in its mission. Those looking to learn more about how StrongRoom AI can support their healthcare facility can find more information at https://strongroom.ai/demo/.

Funding Stage	Amount	Investors	Lead Investors	Date
Non Equity Assistance	Undisclosed	1	WorldUpstart	31 Aug 2023
Seed Round	Undisclosed	3	Artesian, InterValley Ventures +1	21 Jun 2022
Seed Round	Undisclosed	1	Tyson & Blake	20 Jan 2022
Pre Seed Round	$20.00K	1	Melbourne Accelerator Program (MAP)	18 May 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Non Equity Assistance

Undisclosed

WorldUpstart

31 Aug 2023

Seed Round

Undisclosed

Artesian, InterValley Ventures +1

21 Jun 2022

Seed Round

Undisclosed

Tyson & Blake

20 Jan 2022

Pre Seed Round

$20.00K

Melbourne Accelerator Program (MAP)

18 May 2020

FAQ About StrongRoom AI

AI-driven controlled drugs management platform aimed at reducing adverse drug events.

StrongRoom AI was founded in 2017.

StrongRoom AI is headquartered in Australia.

StrongRoom AI operates in AI and Computer Vision. Its work centres on AI-driven platform, medication management, adverse drug events and clinical administration.

StrongRoom AI has approximately 51 employees.

StrongRoom AI has completed 4 funding rounds, raising a total of $20.00K. The latest funding stage is Non Equity Assistance.

Top alternatives and competitors to StrongRoom AI include Oatmeal Health, Nay.AI, Virgo, Coram AI, ezClinic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

StrongRoom AI and Oatmeal Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

StrongRoom AI

General Information

Discover More

About StrongRoom AI

Funding Rounds & Investors (4)

StrongRoom AI Alternatives & Competitors

FAQ About StrongRoom AI